You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 8, August 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Abstract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Articles for Residents
 •Glaucoma
 •Ophthalmological Procedures, Other
 •Alert me on articles by topic

Clinical Comparison of the Proview Eye Pressure Monitor With the Goldmann Applanation Tonometer and the TonoPen

Junping Li, MD, PhD; Leon W. Herndon, MD; Sanjay G. Asrani, MD; Sandra Stinnett, DrPH; R. Rand Allingham, MD

Arch Ophthalmol. 2004;122:1117-1121.

ABSTRACT

Objective  To compare intraocular pressure (IOP) values obtained by patients using the new Proview eye pressure monitor (Bausch & Lomb, Rochester, NY) with those measured with the Goldmann tonometer and the TonoPen (Mentor, Norwell, Mass).

Methods  Eighty-six patients (a total of 171 eyes) with a diagnosis of glaucoma or glaucoma suspect successfully completed the study. The IOP was measured by 3 methods in the following order: Goldmann tonometer, TonoPen, and Proview eye pressure monitor. The central corneal thickness was measured by an ultrasonic pachymeter. Separately for each eye, the differences in mean IOP values between measurement methods were assessed with paired t tests and also in multivariate models that tested the dependence of IOP difference on central corneal thickness.

Results  There was a significant difference (P<.001) in the mean IOPs measured by the 3 different methods (Goldmann vs Proview, Goldmann vs TonoPen, and TonoPen vs Proview) for both eyes, and the difference was independent of the central corneal thickness. The differences between IOP measured by Goldmann and Proview were similar in all categories of patient-reported ease of using the Proview.

Conclusions  The IOPs obtained with the Proview eye pressure monitor are significantly lower than those measured with Goldmann tonometer and the TonoPen, and variations of the central corneal thickness do not contribute to the difference. Intraclass correlations of IOP values obtained with the Goldmann and the Proview or TonoPen and Proview are not strong. On the other hand, as expected, measurements with Goldmann and TonoPen agreed fairly well.



INTRODUCTION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Elevated intraocular pressure (IOP) is one of the most important risk factors for glaucoma, and it is currently the only treatable measure of the disease. Therefore, it is imperative to have an accurate measurement of the IOP in the care of patients with glaucoma. Since its introduction in the 1950s, the Goldmann applanation tonometer has been the gold standard for measuring IOP. However, this instrument can be used only in a physician's office, where a "snapshot" of the IOP is taken.

It is well known that there are circadian variations of the IOP, and these fluctuations are more pronounced in patients with glaucoma.1-2 Studies have demonstrated that IOP peaks and, more importantly, IOP fluctuations are associated with progression of visual field loss in patients with glaucoma even though their office IOP was in the normal range.3-4

Over the years, various portable tonometers have been developed; these include the Perkins,5 TonoPen (Mentor, Norwell, Mass),6 Zeimer and coworkers' self-tonometer,7 Ocuton-S (EPSa Elektronik & Praezisionsbau, Saalfeld, Germany),8 and ProTon (Tomey, Erlangen, Germany).9 These instruments are costly and require a skilled operator. The Schiøtz tonometer that was developed in the early 20th century is also portable and is inexpensive. However, patients have to be in the supine position, and there are multiple sources of error with this technique.

The Proview eye pressure monitor (Bausch & Lomb, Rochester, NY) uses a psychophysical test based on the entoptic phenomenon of pressure phosphenes to evaluate IOP, and it was designed for the patient to use at home. It is a pencillike device that has a small flat probe, an internal spring, and a readable pressure scale (Figure 1). The device measures the IOP through the eyelid, and it does not require an anesthetic. It is safe, noninvasive, portable, and affordable, and requires no electric or battery source. If proven reliable, the Proview eye pressure monitor could be an important instrument in the detection and management of glaucoma.



View larger version (29K):
[in this window]
[in a new window]
Figure 1. The Proview eye pressure monitor (Bausch & Lomb, Rochester, NY).


A previous study demonstrated close agreement between the Goldmann tonometer and the pressure phosphene tonometer when the IOP measurements by both methods were performed by clinicians.10 However, it is not known whether the results would be the same if patients themselves took the pressure measurements with the Proview. Therefore, the current study was designed to compare the IOP readings obtained by patients using the Proview with those obtained by physicians using the Goldmann and TonoPen instruments, and to assess the ease and discomfort associated with the use of Proview.


METHODS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Patients with a diagnosis of glaucoma or glaucoma suspect were recruited from the Glaucoma Service of Duke University Eye Center, Durham, NC. The study protocol was approved by the institutional review board of Duke University, and informed consent was obtained from all participants. Inclusion criteria were age greater than 19 years, diagnosis of glaucoma (with mild visual field defect such as early nasal steps) or glaucoma suspect, IOP by Goldmann tonometry greater than 8 mm Hg, and visual acuity of 20/80 or better. Exclusion criteria were tremor, previous penetrating keratoplasty or abnormal cornea precluding accurate measurement of IOP by Goldmann tonometry, or temporal visual field defects that prevented perception of the phosphene. The IOP was measured by 3 methods in the following order: Goldmann tonometer, TonoPen, and Proview eye pressure monitor. Skilled clinicians performed Goldmann tonometry and TonoPen tonometry, and patients obtained measurements with the Proview eye pressure monitor. Two readings were made for each method and the average was used in the analysis.

Goldmann tonometry was performed in a standard manner. For TonoPen tonometry, the instrument was calibrated each day before use, and readings of the highest reliability (standard error of the mean, ≤5% of the average) were obtained.

Patients were then asked to obtain IOP readings with the Proview device. They were given the diagrammed instruction sheet from the manufacturer, and a clinician went over the steps with them before the procedure. The right hand was used to hold the device and measure IOP in the left eye, and the left hand to measure IOP in the right eye. In brief, the patient was instructed to keep the head straight and look down and to the side. While keeping the eyelid partially open, the patient gently pressed the Proview probe against the upper eyelid just below the edge of the eyebrow at the top of the nose (Figure 2). The pressure was slowly increased until a dark spot surrounded with a ring of light, a phosphene, was perceived. The device was then immediately removed and measurement on the scale was recorded. A 2-minute interval was allowed between the different methods. The central corneal thickness (CCT) was measured by an ultrasound pachymeter (Pachette 2; DGH Technology Inc, Exton, Pa). Six readings were taken and averaged. In addition, the ease of using the Proview eye pressure monitor and the discomfort associated with its use were assessed.



View larger version (55K):
[in this window]
[in a new window]
Figure 2. A patient measuring her intraocular pressure by using the Proview eye pressure monitor (Bausch & Lomb, Rochester, NY).


Separately for each eye, the differences in mean IOP values between measurement methods were assessed by paired t tests and also in multivariate models that tested the dependence of IOP difference on CCT with the Wilks {Lambda} test. Intraclass correlations of IOP values for measurement methods were computed separately for the right and left eyes. An analysis of variance was used to determine whether there was a difference among categories of ease for the difference between the IOPs measured by the Goldmann and Proview instruments.


RESULTS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Ninety-one patients were recruited into the study and 86 successfully completed the study. Five subjects were unable to successfully perform IOP measurement with the Proview instrument because they either were unable to see the phosphene or could not physically perform the procedure. Of the 86 participants, 48 were female and 38 male. The age of the patients ranged from 27 to 83 years, and visual acuity from 20/20 to 20/80. No discomfort was associated with the use of the Proview eye pressure monitor.

Ease of use of the Proview was assessed by the following grading system: 1, very easy; 2, easy; 3, moderate; 4, difficult; and 5, very difficult. Seventy patients (81%) described using the Proview as "easy" or "very easy," whereas 6 (7%) described its use as "difficult." The mean CCT was 549 µm (range, 449-637 µm) in the right eye and 552 µm (range, 452-629 µm) in the left. In the right eye, the mean IOPs were 17.2 mm Hg (range, 9-44 mm Hg), 15.6 mm Hg (10-39.5 mm Hg), and 13.8 mm Hg (8-27.5 mm Hg) by Goldmann, TonoPen, and Proview, respectively, and in the left eye, the values were 16.2 mm Hg (8.5-25 mm Hg), 14.7 mm Hg (8-23.5 mm Hg), and 13.4 mm Hg (8-23 mm Hg), respectively.

There was a significant difference (P<.001) between methods for the mean IOP measurements in both eyes (Table 1). For Goldmann and Proview, the difference in IOP measurements was similar across a wide spectrum of corneal thickness (Figure 3). The Wilks {Lambda} test indicated that the difference was independent of CCT (P = .70 for the right eye and P = .26 for the left eye). In the right eye, only 30% of the Proview readings were within ±2 mm Hg of the Goldmann readings and 51% within 3 mm Hg; these figures were 47% and 61%, respectively, for the left eye (Figure 4). The relationship between the IOP values obtained with Goldmann and Proview are shown in Figure 5; for Goldmann and TonoPen in Figure 6; and for Proview and TonoPen in Figure 7. The intraclass correlations between the IOP values obtained with Goldmann and Proview were 0.07 for the right eye and 0.23 for the left eye. For Goldmann and TonoPen, the coefficients were 0.79 and 0.78 for the right and left eyes, respectively. For TonoPen and Proview, the intraclass correlations were 0.20 and 0.39 for the right and left eyes, respectively. The differences between IOP measured by Goldmann and Proview were similar in all categories of patient-reported ease of using the Proview, and there was no statistical significance for either eye (Table 2).


View this table:
[in this window]
[in a new window]
Table 1. Difference in IOP Between Methods*




View larger version (63K):
[in this window]
[in a new window]
Figure 3. Intraocular pressure (IOP) measurements by Goldmann and Proview (Bausch & Lomb, Rochester, NY) instruments as related to corneal thickness in the right eye (A) and left eye (B). In the right eye, the IOP difference between the 2 methods was similar across a spectrum of corneal thicknesses. In the left eye, it showed a tendency to increase with the corneal thickness, but the increase was not statistically significant (P = .26).




View larger version (30K):
[in this window]
[in a new window]
Figure 4. Frequency histogram of intraocular pressure (IOP) differences between Goldmann and Proview (Bausch & Lomb, Rochester, NY) instruments in the right eye (A) and left eye (B).




View larger version (28K):
[in this window]
[in a new window]
Figure 5. Correlation of intraocular pressure (IOP) measurements between Goldmann and Proview (Bausch & Lomb, Rochester, NY) instruments in both right (A) and left (B) eyes.




View larger version (28K):
[in this window]
[in a new window]
Figure 6. Correlation of intraocular pressure (IOP) measurements between Goldmann and TonoPen (Mentor, Norwell, Mass) instruments in both right (A) and left (B) eyes.




View larger version (28K):
[in this window]
[in a new window]
Figure 7. Correlation of intraocular pressure (IOP) measurements between Proview (Bausch & Lomb, Rochester, NY) and TonoPen (Mentor, Norwell, Mass) instruments in both right (A) and left (B) eyes.



View this table:
[in this window]
[in a new window]
Table 2. Difference in IOP by Goldmann and Proview* Instruments for Each Category of Ease



COMMENT
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Invented by Fresco,10 the Proview eye pressure monitor is based on an entoptic phenomenon or phosphene (Greek for "to show a light"), which is a sensation of light elicited by nonphotic stimuli. The likely basis of its operation was thought to follow the Imbert-Fick law: the perception of a phosphene occurs when the retina is deformed, which occurs with the application of a force over a given area, which can then be related to pressure.10 The site of a phosphene in the retina was suggested to be bipolar cells, or the parts of rod and cone cells lying inside the external limiting membrane.11

We separately analyzed IOP measurements obtained with the Proview from each eye because measurements were obtained with different hands. Although the IOP difference between the Goldmann and Proview was smaller for the left eye (a mean of 2.78 mm Hg vs 3.40 mm Hg), it was statistically significant for both eyes (P<.001 for both eyes).

It is not known whether the position of the eye on inferior temporal rotation when the Proview was used affects the IOP and therefore the measurement readings. However, this is unlikely a significant factor. Axial length, refractive status, condition of the vitreous, and previous eye surgery may play a role in the IOP measurements with the Proview, and these were not analyzed in the present study.

Two recent abstracts published by the Association for Research in Vision and Ophthalmology reported a mean difference in IOPs between the Proview and Goldmann instruments of 0.5 mm Hg (with a range from –5 to +16 mm Hg)12 and 3.2 mm Hg.13 The IOPs obtained with the Proview eye pressure monitor in our study were significantly lower than those measured with Goldmann tonometer and the TonoPen. It is a remote possibility that the order in which the IOP was taken contributed significantly to the difference because at least 2 minutes was allowed to elapse between measurement methods. Recep et al14 noted that the time interval between successive IOP measurements should be 2 or 10 minutes for accurate tonometry. The mean IOPs measured by TonoPen were lower than those by Goldmann tonometry. Although the TonoPen tonometry was always performed after Goldmann tonometry, we do not believe that drying and therefore thinning of the cornea is a factor responsible for the IOP difference, because patients were frequently reminded to blink their eyes during the measurements. It is well known that the CCT affects the measurement of IOP by Goldmann tonometer15-17 and, to a lesser degree, by TonoPen,18-19 although contradictory reports exist in the literature.20-21 A meta-analysis of literature found that the mean corneal thickness of eyes reported to be normal was 544 µm by ultrasonic pachymetry.16 The mean CCT in our group of patients was 549 µm (right eye) and 552 µm (left eye). Race, age, sex, and a history of diabetes have all been reported to influence corneal thickness,15, 17, 22 and our group of patients was not homogeneous.

Theoretically, the IOP measurements with the Proview should not be influenced by corneal thickness, and this was found to be the case in a group of 22 patients undergoing laser in situ keratoplasty.13 Therefore, we analyzed the dependence of IOP difference between the Goldmann and Proview on corneal thickness, in an effort to determine whether the underestimation or overestimation of IOPs by Goldmann tonometry was based on differences in CCT. The CCT in our patients ranged from 449 to 637 µm, and these wide variations did not contribute to the IOP difference obtained with the 2 methods. Regardless of the CCT, a similar IOP difference was present. Scleral thickness differences may play a role in the accuracy of the Proview, but its influence has not yet been determined.

We also determined whether the difficulty with use of the Proview could explain the discrepancy in IOP readings compared with the Goldmann instrument, and we found no difference in all categories of patient-reported ease of using the device. Further analysis showed no strong correlation between the IOPs measured with the Goldmann and Proview, and no correction factor could be derived and used to accurately estimate the IOP with this new device. In fact, the Proview tonometer was found to act like a spring moving inside a cylinder with friction, leading to nonlinearity and irreproducibility.23 Further studies are needed in larger samples to assess whether the Proview will allow us to gauge a range of IOP fluctuation in the same patient.

In summary, we found that the IOPs obtained with the Proview eye pressure monitor were significantly lower than those measured with the Goldmann tonometer and the TonoPen. Furthermore, the intraclass correlation between the IOP values obtained with the Goldmann and the Proview instruments was low, indicating very little agreement between these 2 methods of measuring IOP. Therefore, these data suggest that the IOPs measured by the Proview eye pressure monitor do not correlate well with those obtained by Goldmann tonometer. Whether the IOP measurements by the Proview are reproducible for a specific individual patient and, if so, whether the difference compared with Goldmann tonometry is constant over a range of IOPs in the same patient need to be determined. Nevertheless, our results demonstrated that the Proview eye pressure monitor failed to measure the IOP accurately in our study sample of patients.


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Correspondence: Leon W. Herndon, MD, Department of Ophthalmology, Duke Eye Center, PO Box 3802, Erwin Road, Durham, NC 27710 (hernd012{at}mc.duke.edu).

Submitted for publication June 16, 2003; final revision received December 9, 2003; accepted January 9, 2004.

This study was supported in part by Clinical Vision Research Development Award EY 11725 from the National Eye Institute, National Institutes of Health, Bethesda, Md (Dr Stinnett).

From the Department of Ophthalmology, University of South Carolina School of Medicine, Columbia (Dr Li); and Departments of Ophthalmology (Drs Herndon, Asrani, Stinnett, and Allingham) and Biostatistics and Bioinformatics (Dr Stinnett), Duke University Medical Center, Durham, NC. The authors have no relevant financial interest in this article.


REFERENCES
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

1. Wilensky JT. Diurnal variations in intraocular pressure. Trans Am Ophthalmol Soc. 1991;89:757-790. PUBMED
2. David R, Zangwill L, Briscoe D, Dagan M, Yagev R, Yassur Y. Diurnal intraocular pressure variations. Br J Ophthalmol. 1992;76:280-283. FREE FULL TEXT
3. Zeimer RC, Wilensky JT, Gieser DK, Viana MA. Association between intraocular pressure peaks and progression of visual field loss. Ophthalmology. 1991;98:64-69. ISI | PUBMED
4. Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9:134-142. ISI | PUBMED
5. Perkins ES. Hand-held applanation tonometer. Br J Ophthalmol. 1965;49:591-593. FREE FULL TEXT
6. Frenkel RP, Hong YJ, Shin DH. Comparison of the Tono-Pen to the Goldmann application tonometer. Arch Ophthalmol. 1988;106:750-753. ABSTRACT
7. Zeimer RC, Wilensky JT, Gieser DK, Mori MM, Baker JP. Evaluation of a self tonometer for home use. Arch Ophthalmol. 1983;101:1791-1793. ABSTRACT
8. Kothy P, Vargha P, Hollo G. Ocuton-S self tonometry vs Goldmann tonometry: a diurnal comparison study. Acta Ophthalmol Scand. 2001;79:294-297. PUBMED
9. Pandav SS, Sharma A, Gupta A, Sharma SK, Gupta A, Patnaik B. Reliability of ProTon and Goldmann application tonometer in normal and postkeratoplasty eyes. Ophthalmology. 2002;109:979-984. FULL TEXT | ISI | PUBMED
10. Fresco BB. A new tonometer—the pressure phosphene tonometer: clinical comparison with Goldmann tonometry. Ophthalmology. 1998;105:2123-2126. FULL TEXT | ISI | PUBMED
11. Brindley GS. The site of electrical excitation of the human eye. J Physiol. 1955;127:189-200.
12. Gallance SA, Fechtner RD, Realini AD, et al. Clinical comparison of the Proview eye pressure monitor with Goldmann applanation tonometry in healthy eyes [ARVO abstract]. Invest Ophthalmol Vis Sci. 2002;43(suppl). Program 1067.
13. Naruse S, Mori K, Kojo M, Hieda O, Kinoshita S. Evaluation of intraocular pressure change after laser in situ keratomileusis using pressure phosphene tonometer [ARVO abstract]. Invest Ophthalmol Vis Sci. 2002;43(suppl). Program 2114.
14. Recep OF, Hasiripi H, Vayisoglu E, Kalayci D, Sarikatipoglu H. Accurate time interval in repeated tonometry. Acta Ophthalmol Scand. 1998;76:603-605. PUBMED
15. Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997;115:1137-1141. ABSTRACT
16. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measurements. Surv Ophthalmol. 2000;44:367-408. FULL TEXT | ISI | PUBMED
17. Brandt JD, Beiser JA, Kass MA, Gordon MO. Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology. 2001;108:1779-1788. FULL TEXT | ISI | PUBMED
18. Bhan A, Browning AC, Shah S, Hamilton R, Dave D, Dua HS. Effect of corneal thickness on intraocular pressure measurements with the pneumotonometer, Goldmann applanation tonometer, and Tono-Pen. Invest Ophthalmol Vis Sci. 2002;43:1389-1392. FREE FULL TEXT
19. Dohadwala AA, Munger R, Damji KF. Positive correlation between Tono-Pen intraocular pressure and central corneal thickness. Ophthalmology. 1998;105:1849-1854. FULL TEXT | ISI | PUBMED
20. Mok KH, Wong CS, Lee VW. Tono-Pen tonometer and corneal thickness. Eye. 1999;13:35-37.
21. Feltgen N, Leifert D, Funk J. Correlation between central corneal thickness, applanation tonometry, and direct intracameral IOP readings. Br J Ophthalmol. 2001;85:85-87. FREE FULL TEXT
22. Foster PJ, Baasanhu J, Alsbirk PH, Munkhbayar D, Uranchimeg D, Johnson GJ. Central corneal thickness and intraocular pressure in a Mongolian population. Ophthalmology. 1998;105:969-973. FULL TEXT | ISI | PUBMED
23. Thomas GA, Marchetto P, Greene R, Fechtner RD. Mechanical analysis of a patient-operated tonometer [ARVO abstract]. Invest Ophthalmol Vis Sci. 2002;43(suppl). Program 3426.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Longitudinal Study to Establish the Normative Value and to Evaluate Perinatal Factors Affecting Intraocular Pressure in Preterm Infants
Ng et al.
IOVS 2008;49:87-92.
ABSTRACT | FULL TEXT  

Clinical Comparison of the Proview Eye Pressure Monitor With the Goldmann Applanation Tonometer and the TonoPen--Reply
Herndon et al.
Arch Ophthalmol 2005;123:579-580.
FULL TEXT  

Clinical Comparison of the Proview Eye Pressure Monitor With the Goldmann Applanation Tonometer and the TonoPen
Leung and Lam
Arch Ophthalmol 2005;123:578-579.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.